Home South African Testing underway to determine effectiveness of arthritis drug as coronavirus treatment

Testing underway to determine effectiveness of arthritis drug as coronavirus treatment

120
SHARE

A clinical trial of the rheumatoid arthritis drug Kevzara as a treatment for the coronavirus has started.

Sanofi SA and partner

Regeneron Pharmaceuticals Inc have started a clinical

trial of their rheumatoid arthritis drug Kevzara as a treatment

for the coronavirus, the companies said on Monday.

Enrolments for the mid-to-late stage trial will begin

immediately, and the companies anticipate the trial will test up

to 400 patients.

Kevzara is an infection-fighting protein known as monoclonal

antibody.

Regeneron in February announced a partnership with the US Department of Health and Human Services to develop a coronavirus

treatment, and had said it would focus on monoclonal antibodies.

* For the latest on the Covid-19 outbreak visit IOL’s #Coronavirus trend page.

** If you think you have been exposed to the Covid-19 virus, please call the 24-hour hotline on 0800 029 999 

*** Receive IOL’s top stories via Whatsapp by sending your name to 0745573535 

**** Follow IOL on Facebook

 and Twitter

 to join the conversation and stay updated with the latest news.

Reuters